Who We Are
BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.
Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.
Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.
About Commercial
Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific.
Overview: BioMarin is a leader in delivering therapeutics for rare genetic diseases. We focus on advancing therapies that provide meaningful advances to patients, particularly children, who live with serious and life-threatening conditions.
Role Summary: The Senior Field Clinical Coordinator (Sr-FCC) educates patients and caregivers on the safe and appropriate use of BioMarin therapies, specifically supporting Voxzogo product initiation and ongoing therapy. Sr-FCCs collaborate with clinics and the BioMarin account team, working from home to support patients in a designated region both virtually and through in-home visits with patients and caregivers.

EXPERIENCE AND EDUCATION:

• 3+ years of pharmaceutical experience as a patient educator.
• 4+ years of direct patient care experience in rare diseases.
• Education as an allied health care professional.

REQUIREMENTS:

• Successful background check.
• Valid driver’s license and driving record.
• Willingness to travel to see patients in their homes. Some overnight travel required (up to 30%).
  Location: Washington DC, Philadelphia, Baltimore
  Equal Opportunity Employer/Veterans/Disabled
  An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
  The salary range for this position is: $122,000 to $167,750. BioMarin considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans.

For additional benefits information, visit: https://careers.biomarin.com/benefits.

• Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

• Collaborate with clinics, BioMarin field sales, and RareConnections personnel to ensure timely therapy initiation and adherence.
• Work within an account team to move cases from referral to product start.
• Educate patients and caregivers on BioMarin products, including safety, efficacy, dosing, administration, and storage.
• Provide in-person reinforcement of injection training as needed.
• Use motivational interviewing to empower patients and caregivers.
• Conduct ongoing education on disease and product administration.
• Participate in patient educational events approximately three times a year.